Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently... see more

OTCPK:ARLZQ - Post Discussion

View:
Post by kuatolives on May 09, 2017 12:11am

88 Cents tomorrow

That's my guess. Anyone want in on the pool?
Comment by biggerr on May 09, 2017 12:49am
$2 tomorrow on good Zon sales guidanca, haaaaaaa
Comment by biggerr on May 09, 2017 12:52am
$2.50 by Friday
Comment by Floridas2000 on May 09, 2017 8:18am
My bet is 50 cents by the end of the week!
Comment by kuatolives on May 09, 2017 11:54am
I like how their new direction (this time) is to concentrate on the Canadian market. You mean Tribute products?! Wow. What a bunch of effing geninuses.
Comment by biggerr on May 09, 2017 12:54pm
actually their guidance could be conservative because at $10/month Yosprala is just about the same price as regular aspirin but with the PPI in it to prevent aspirin from burning a hole in your stomach. They could easily get 1 million users @ $120/year 
Comment by kuatolives on May 09, 2017 2:20pm
They could also easily go straight to zero with a bullet.
Comment by snootchybootchy on May 09, 2017 4:09pm
I tihnk you read that incorrectly.  That $10/month is just the co-pay.   Been too busy today to listen to the conference call but the financials were surprisingly good.  The cash burn has also been cut more than I thought and gives us time to develop the market for Zontivity and increase uptake of Yosprala at the new reduced prices.  Mr. Adams has alot of skin in the game so ...more  
Comment by biggerr on May 09, 2017 6:08pm
you're right, the PPI alone in Yos costs much more than $10
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities